Rising Rates of Teenage E-cigarette Use in the US

Oct.20.2022
Rising Rates of Teenage E-cigarette Use in the US
Teenage e-cigarette use rises in the US, with 14.1% of high school students and 3.3% of middle school students using them. Experts warn of health risks.

The proportion of teenagers using e-cigarettes has increased once again, according to a report released by the US Centers for Disease Control and Prevention. The National Youth Tobacco Survey, led by the US Food and Drug Administration and the CDC, showed that 14.1% of high school students and 3.3% of middle school students reported using e-cigarettes or other vaping products in the recent past. These figures suggest that approximately 2.5 million middle and high school students in the US are now vaping. Experts are particularly concerned that over a quarter of students are using e-cigarettes on a daily basis.


Dr. Ramiro Fernandez, Assistant Professor at the Division of Thoracic Surgery under Dr. David J. Sugarbaker at the Michael E. DeBakey College of Medicine, states that while extensive long-term data on the effects of electronic cigarettes are lacking, we are aware of acute lung injuries associated with their use, known as EVALI or electronic cigarette-associated lung injury.


Patients with EVALI experience respiratory symptoms and signs, including shortness of breath and decreased oxygen levels. They may also develop severe diffuse inflammation in their lungs, which can lead to death," said Fernandez. As of February 2020, there have been 2,807 reported cases of hospitalization or death due to EVALI, with 68 confirmed deaths.


Most e-cigarettes contain nicotine. In fact, a study by the Centers for Disease Control and Prevention found that 99% of e-cigarettes sold in assessment locations in the US contained nicotine. Nicotine can harm the developing brains of adolescents, which do not fully mature until around age 25. Additionally, research shows that teenagers who use e-cigarettes are more likely to start smoking traditional cigarettes in the future.


Electronic cigarettes also contain other harmful substances, such as ultrafine particles that can be inhaled deep into the lungs, flavorings associated with serious lung diseases, heavy metals like nickel, tin, and lead, as well as other carcinogens.


According to the American Cancer Society, the aerosol in e-cigarettes contains addictive substances that can lead to lung disease, heart disease, and cancer. A study by Johns Hopkins University in October 2021 on the components of e-cigarettes shows that there are thousands of chemical components in e-cigarette products, many of which have not been identified. The research team identified a pesticide, three chemicals never before found in e-cigarettes, and two flavorings associated with respiratory irritation and potential toxicity.


Although some people believe that electronic cigarettes can help people quit smoking, they have not been approved by the Food and Drug Administration as an aid. To quit smoking, seek help from your doctor or other support services, such as the smoking cessation program at the Baylor College of Medicine's Chest Clinic. It is important to note that electronic cigarettes are harmful not only to young people but also to adults.


People need to know that electronic cigarettes are harmful to your health," Dr. Fernandez stated. "Although the long-term effects are still unclear, data shows noticeable risks to cardiovascular and lung health.


For more information and resources, please see Baylor College of Medicine's position paper on taking action to address the issue of youth smoking and vaping.


Author: Tiffany Harston, Assistant to the Michael E. DeBakey Surgical Communications at Baylor College of Medicine.


Statement:


This article is compiled from third-party information and is intended for industry professionals for informational and educational purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The article's translation is only intended for internal industry exchange and research purposes.


Due to the limitations of the compiler's skills, the translated article may not express the same meaning as the original. Please refer to the original article for accuracy.


In regards to any domestic, Hong Kong/Macau/Taiwan-related, or foreign statements and positions, 2FIRSTS is fully aligned with the Chinese government.


The copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
Huabao’s H1 2026 results show the company advancing across three connected fronts: international expansion, entry into next-generation tobacco supply chains and diversification beyond its traditional tobacco-related base. Overseas revenue rose 216.08% to CNY 96.02 million, while non-flavor businesses reached 42.2% of total revenue. Huabao also said it had entered the supply chains of leading global tobacco customers, as its nutrition, food ingredient, fragrance and personal-care businesses gained ground in Europe, Southeast Asia, Australia and New Zealand. However, adjusted net profit increased only 2.78%, and next-generation tobacco revenue was not separately disclosed, showing that the transformation is reshaping revenue and customer exposure but has yet to translate fully into underlying earnings.
Aug.28
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's liquid-vape market is showing changes across raw-material imports, product types and sales channels after synthetic nicotine came under the Tobacco Business Act on April 24. Customs data show nicotine-analogue imports totaled 12,126 kilograms from April through August, while synthetic-nicotine imports over the same five months totaled 231,663 kilograms, just 39.3% of the amount imported in March alone. Physical liquid-vape stores tracked in Seoul and Gyeonggi Province fell 9.9%, unmanned outlets edged higher and online sales listings increased from 27,774 to 42,437. Government testing of 105 liquid inhalation products promoted as nicotine-free separately found nicotine in 13 and 6-methylnicotine in 12.
Sep.22
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus distributor H&S said the zero-nicotine, zero-tar NEO vaping line will begin rolling out across FamilyMart stores in Japan from September 14, 2026, excluding some locations. The DASH line will also be sold at selected FamilyMart stores in southern Kyushu and Okinawa. Snowplus simultaneously named Japanese rock band Kishidan as a brand ambassador, combining convenience-store distribution with a broader consumer marketing push in Japan.
Sep.15
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Philip Morris International has published its first report aligned with the Taskforce on Nature-related Financial Disclosures, bringing its electronics supply chain and the use and end-of-life stages of smoke-free devices and consumables into its nature-related assessment. PMI said its smoke-free business accounted for about 42% of total net revenues in the second quarter of 2026. The report says non-circular electronic products, particularly single-use items, can increase consumption of limited natural resources and also details an IQOS repair pilot. A 2040 circularity scenario tests assumptions including a 50% reduction in product waste-related costs, 10% raw-material savings and a 25% substitution rate for refurbished products versus new products.
Sep.23